Krishna Prasad is the Deputy Director, Innovative Medicines at the UK Regulatory Agency with management responsibility for all therapy areas. Dr Prasad’s additional roles include Cardiology consultancy at St. Thomas’ hospital, London. Dr Prasad’s areas of special interests include heart failure, sudden death, cardiomyopathies and arrhythmias. He is a member of the Cardiovascular working party since 2008, assuming responsibility for coordinating European guidances on heart failure, lipid modifying agents as well as paediatric guidances in these areas. He is participated in many regulatory-scientific dialogues and has a keen interest in global harmonisation of both clinical trials and regulatory guidances. He has served as the Chair of the Pharmacogenomic working party of EMA. He was the Regulatory chair of the ICH expert groups for E-14 ( QT/QTc) and E-18 Genomic sampling guidelines.